ApoE4.Info, Inc and the ApoE4 Alzheimer's Alliance (A3) today announced a strategic partnership to elevate research, education, and public policy efforts focused on individuals who carry the ε4 allele ...

A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 3, 2025, titled "APOE genotype and biological age impact inter-omic associations related to bioenergetics." In this ...

Nine in 10 Alzheimer’s cases would not develop without the contribution of a single gene, nor would almost half of all dementia cases, researchers find. Alzheimer’s is the most common form of dementia ...

More than 9 out of 10 Alzheimer's cases could be driven by specific variations in a single gene and the protein it produces, a new study reveals, suggesting that treatments targeting this well-known ...

The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 ...

THE WHOLE PERSON. I WAS PRETTY SURE I HAD THE GENE BECAUSE OF MY MOM, BECAUSE WE DID DO BRAIN AUTOPSIES ON MY PARENTS, I SEE, AND MY MOM DID HAVE ALZHEIMER’S, AND MY DAD HAD VASCULAR DEMENTIA. SO YOU ...

Variants in a gene called APOE have long been associated with Alzheimer’s disease (AD) and dementia, but a new study suggests we’ve been seriously underestimating their effect. Per this analysis, two ...

A working group of senior investigators, convened by the Alzheimer's Disease Sequencing Project (ADSP), has reached a consensus that the APOE4 gene, long debated in Alzheimer's research, is ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), announced today the launch of the in-vitro diagnostic EURORealTime TM APOE assay in European countries that accept the CE mark, which will ...

Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers. The scientists also found ...